Herramientas de Accesibilidad

LA UDES PUBLICA
Fecha de publicación:
2011-06-10
Tipo:
Article
Número de artículo:
40
Identificación:
SCOPUS_ID:82655177921
eID:
2-s2.0-82655177921
Nombre de la revista:
Frontiers in Systems Neuroscience
Título del artículo:

Nitric oxide synthase inhibitor improves de novo and long-term l-DOPA-induced dyskinesia in hemiparkinsonian rats

Inhibitors of neuronal and endothelial nitric oxide synthase decrease l-3,4-dihidroxifenilalanine (l-DOPA)-induced dyskinesias in rodents. The mechanism of nitric oxide inhibitor action is unknown. The aims of the present study were to investigate the decrease of l-DOPA-induced abnormal involuntary movements (AIMs) in 6-hydroxydopamine (6-OHDA)-lesioned rats by nitric oxide inhibitors following either acute or chronic treatment. The primary findings of this study were that NG-nitro-l-Arginine, an inhibitor of endothelial and neuronal nitric oxide synthase, attenuated AIMs induced by chronic and acute l-DOPA. In contrast, rotational behavior was attenuated only after chronic l-DOPA. The 6-OHDA lesion and the l-DOPA treatment induced a bilateral increase (1.5 times) in the neuronal nitric oxide synthase (nNOS) protein and nNOS mRNA in the striatum and in the frontal cortex. There was a parallel increase, bilaterally, of the FosB/ΔFosB, primarily in the ipsilateral striatum. The exception was in the contralateral striatum and the ipsilateral frontal cortex, where chronic l-DOPA treatment induced an increase of approximately 10 times the nNOS mRNA. Our results provided further evidence of an anti-dyskinetic effect of NOS inhibitor. The effect appeared under l-DOPA acute and chronic treatment. The l-DOPA treatment also revealed an over-expression of the neuronal NOS in the frontal cortex and striatum. Our results corroborated findings that l-DOPA-induced rotation differs between acute and chronic treatment. The effect of the NOS inhibitor conceivably relied on the l-DOPA structural modifications in the Parkinsonian brain. Taken together, these data provided a rationale for further evaluation of NOS inhibitors in the treatment of l-DOPA-induced dyskinesia. © 2011 Padovan-Neto, Echeverry, Chiavegatto and Del-Bel.

Autor(es) UDES:
Echeverry M.B.
Otros Autores:
Padovan-Neto F.E., Chiavegatto S., Del-Bel E.
Autor Principal:
Padovan-Neto F.E.
Áreas del conocimiento:
Neuroscience (miscellaneous), Developmental Neuroscience, Cognitive Neuroscience, Cellular and Molecular Neuroscience
Acerca de la revista donde se publicó este artículo:

Frontiers in Systems Neuroscience

Cuartil Q2
Ranking
3755
Tipo
Journal
ISSN
16625137
Región
Western Europe
País
Switzerland
Cobertura
2007-2022
Logo o escudo de Universidad de Santander UDES - Con acreditación de Alta Calidad (Bucaramanga)
Servicios
Sistema Génesis Sistema GALILEO Directorio Telefónico Chat en línea